David Triplow damaged his spinal cord during his first rugby match for his regiment, the Royal Logistics Corp at Deep Cut Barracks in Surrey He was paralysed from the waist down for several weeks Mr Triplow underwent a nine-hour operation to pin his spine back together Battled back to health so he could walk with his girlfriend down the aisle He is now training to take part in the Great North Run next month By Emma Innes PUBLISHED: 11:34 EST, 26 August 2013 | UPDATED: 12:15 EST, 26 August 2013 27 shares 13 View comments A soldier who was told he might never walk again after he broke his neck is set to take part in the Great North Run. David Triplow suffered a devastating injury while playing his first game of rugby for his regiment, but has amazed doctors by battling back to health. The 32-year-old, of Whitburn, South Tyneside, shattered his neck but has since recovered sufficiently to walk his girlfriend, Michelle, 28, down the aisle. David Triplow, 32, broke his neck and damaged his spinal cord while playing his first game of rugby for his regiment. He has amazed doctors by battling back to health and is … Continue reading →

Las Vegas, NV (PRWEB) August 26, 2013 The premier pain management clinic in Henderson and Las Vegas, Innovative Pain Care, is now offering cutting edge treatment for chronic low back and neck pain. Spinal cord stimulator implants offer an excellent chance of obtaining relief for pain, with many patients able to get back to work and decrease pain medications necessary. Call (702) 323-0553 for more information and scheduling to find out more. According to the Institute of Medicine, over 100 million Americans suffer from chronic pain. This is about one third of the population, and unfortunately a number of individuals have already tried significant treatment. Innovative Pain Care Center has a Double Board Certified Las Vegas pain management doctor, Dr. Daniel Burkhead, who is highly skilled in spinal cord stimulator implants. For patients dealing with failed back surgery syndrome or neck pain that has not responded to other treatments, spinal cord stimulation may provide immense relief. The clinics have two locations, one in Las Vegas and the other in Henderson. These implants are often able to mask a person's pain and replace it with a tingling sensation. For a person who has no further surgical option, the implant may be … Continue reading →

LAUSANNE, Switzerland, August 29, 2013 /PRNewswire/ -- Debiopharm Group (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs targeting unmet medical needs as well as companion diagnostics, presents today the 'Debiopharm Group Life Sciences Award 2013' to Professor Grgoire Courtine for his outstanding research on 'Restoring Motor Functions after Spinal Cord Injury'. The two 'Junior Debiopharm Group Life Sciences Awards 2013'areattributed to Dr Leanne Li for her research on cancer and the nervous system and to Dr Stphane Baudoin for his work on the heterogeneity of psychiatric disorders. Organized by the Brain Mind Institute (BMI), the ceremony will take place today at the EPFL (Ecole polytechnique fdrale de Lausanne) during the Annual EPFL SV- Life Science Symposium 2013. The theme of this year's symposium is 'Motor Control - from neural circuits and diseases to neuroprosthetics.' This year's award honors Prof. Grgoire Courtine from the International Paraplegic Foundation (IRP) Chair in Spinal Cord Repair, the Center for Neuroprosthetic and Brain Mind Institute, EPFL and adjunct Professor from the University Hospital of Vaud (CHUV). His research on restoring motor function in severely paralyzed people won him the amount of CHF 50'000 of which CHF 40'000 are made … Continue reading →

MENLO PARK, Calif. & NAPA, Calif.--(BUSINESS WIRE)-- Spinal Modulation, Inc., a privately held global medical device company, today announced the first patient enrollment in its U.S. pivotal clinical trial. The ACCURATE Study is a prospective, randomized, multi-center, controlled trial that will evaluate the safety and efficacy of the Axium Neurostimulator System for the treatment of chronic lower limb pain. This announcement was made as industry leaders convened last week at the 20th annual Napa Pain Conference, where data were presented about European experience with the Axium System. This is a landmark study in the field of spinal cord stimulation, said Eric Grigsby, M.D., founder and medical director of the Napa Pain Institute and the centers principal investigator. The Axium System targets the dorsal root ganglion (DRG), a unique branch of the spinal cord that plays a critical role in the development and maintenance of chronic pain1. The recently published European data2 from a non-randomized study are promising 78 percent of patients experienced pain relief in the lower limbs. I am excited to be the first in the country to participate in this important clinical trial. The study is expected to enroll 152 patients in up to 25 medical centers in … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced an update on the clinical timeline for its biopolymer scaffolding to treat acute SCI. The Company now expects that, based on the judgment of new management, it will enroll the first patient during the first quarter of 2014. Under the conditions of the FDAs approval of the Investigational Device Exemption, the five-person pilot trial will be staggered such that each patient will be followed for three months prior to requesting approval to enroll the next patient. Because the Company must obtain FDA approval to enroll each subsequent patient, the Company anticipates that from the date of the first enrolled patient, it will take at least 21 months to complete enrollment. Consistent with FDA guidance, the Company then expects to conduct a pivotal study with a control group to obtain FDA approval to commence commercialization under a Humanitarian Device Exemption. Michael Astrue, Interim Chief Executive Officer of InVivo, said, We remain fully committed to beginning this study as soon as possible. While the study will take additional time, we look forward to bringing this … Continue reading →